1) Translational Medicine: Collaborating with laboratory scientists, students, and technicians to translate bench-side cancer research into clinical trials for patients.

2) Cellular Immunotherapy: Partnering with physicians and researchers across Canada to advance Chimeric Antigen Receptor T-cell (CAR-T) therapy through the Canadian-Led Immunotherapies in Cancer (CLIC) program, making innovative treatments accessible to Canadian patients.

3) Hematologic Malignancies: Focused on improving outcomes for recipients of stem cell transplants and CAR-T therapies, with an emphasis on long-term recovery and disease management.

4) Clinical Epidemiology: Applying statistical methods in health economics, patient-reported outcomes, engagement strategies, and systematic reviews to enhance care for patients with hematologic cancers, particularly those undergoing transplantation.